HCM
GILD icon

Hodges Capital Management’s Gilead Sciences GILD Stock Holding History

Hodges Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
9,315
+597
+7% +$78.7K 0.08% 158
2026
Q1 		$1.22M Buy
8,718
+146
+2% +$20.4K 0.1% 136
2025
Q4 		$1.05M Sell
8,572
-63
-0.7% -$7.66K 0.09% 137
2025
Q3 		$958K Buy
+8,635
New +$981K 0.08% 141
2025
Q2 		– Sell
-1,700
Closed -$3.83M – 214
2025
Q1 		$3.83M Buy
+1,700
New +$175K 0.38% 81
2018
Q4 		– Sell
-4,720
Closed -$364K – 239
2018
Q3 		$364K Sell
4,720
-25
-0.5% -$1.89K 0.03% 207
2018
Q2 		$336K Sell
4,745
-10,160
-68% -$717K 0.02% 211
2018
Q1 		$1.12M Sell
14,905
-1,928
-11% -$153K 0.09% 143
2017
Q4 		$1.21M Sell
16,833
-23,806
-59% -$1.81M 0.09% 135
2017
Q3 		$3.29M Buy
40,639
+5,893
+17% +$451K 0.22% 95
2017
Q2 		$2.46M Buy
34,746
+9,704
+39% +$646K 0.15% 121
2017
Q1 		$1.7M Sell
25,042
-16,212
-39% -$1.14M 0.08% 139
2016
Q4 		$2.95M Buy
41,254
+18,876
+84% +$1.4M 0.14% 121
2016
Q3 		$1.77M Sell
22,378
-1,272
-5% -$103K 0.09% 132
2016
Q2 		$1.97M Sell
23,650
-1,294
-5% -$115K 0.1% 124
2016
Q1 		$2.29M Sell
24,944
-16,574
-40% -$1.49M 0.11% 122
2015
Q4 		$4.2M Buy
41,518
+23,452
+130% +$2.44M 0.17% 100
2015
Q3 		$1.77M Buy
18,066
+11,204
+163% +$1.24M 0.07% 138
2015
Q2 		$803K Sell
6,862
-2,200
-24% -$240K 0.03% 196
2015
Q1 		$889K Sell
9,062
-1,000
-10% -$102K 0.03% 176
2014
Q4 		$948K Sell
10,062
-157,138
-94% -$16.3M 0.04% 172
2014
Q3 		$17.8M Buy
167,200
+2,220
+1% +$217K 0.74% 53
2014
Q2 		$13.7M Buy
164,980
+34,932
+27% +$2.72M 0.64% 64
2014
Q1 		$9.21M Buy
+130,048
New +$10.2M 0.54% 86

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hodges Capital Management's GILD Position: Q2 2026 in Review

Hodges Capital Management increased its Gilead Sciences (GILD) stake by 6.8% in Q2 2026, buying an estimated $78.7K and bringing the position to 9,315 shares worth $1.18M. The position accounts for 0.08% of the portfolio, ranked #158.

Hodges Capital Management first reported a position in GILD in Q1 2014 and has held it in 24 quarters since. The position peaked at $17.8M in Q3 2014. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Hodges Capital Management held 9,315 shares of Gilead Sciences worth $1.18M as of Q2 2026.
  • Hodges Capital Management bought 597 Gilead Sciences shares in Q2 2026, an estimated $78.7K.
  • Gilead Sciences made up 0.08% of Hodges Capital Management's portfolio in Q2 2026, its #158 holding.
  • Hodges Capital Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 24 quarters since.
  • Hodges Capital Management's Gilead Sciences position peaked at $17.8M in Q3 2014.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Hodges Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.